<div class="container">

<table style="width: 100%;"><tr>
<td>interim.tsd.in</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>
Interim analysis of first stage data of 2-stage 2x2 crossover designs based on
the Inverse Normal method
</h2>

<h3>Description</h3>

<p>Following the design scheme according to <code>power.tsd.in</code> the function
performs the interim analysis of the first stage data.
</p>


<h3>Usage</h3>

<pre><code class="language-R">interim.tsd.in(alpha, weight, max.comb.test = TRUE, targetpower = 0.8,
               GMR1, n1, CV1, df1 = NULL, SEM1 = NULL, theta1, theta2,
               GMR, usePE = FALSE, min.n2 = 4, max.n = Inf,
               fCpower = targetpower, fCrit = "CI", fClower, fCupper, fCNmax,
               ssr.conditional = c("error_power", "error", "no"),
               pmethod = c("exact", "nct", "shifted"))
</code></pre>


<h3>Arguments</h3>

<table>
<tr style="vertical-align: top;">
<td><code>alpha</code></td>
<td>

<p>If one element is given, the overall one-sided significance level (not
the adjusted level for stage 1). In this
case the adjusted alpha levels will be calcualted internally. If two
elements are given, the argument refers to the two adjusted one-sided
alpha levels for stage 1 and
stage 2, respectively.<br>
If missing, defaults to <code style="white-space: pre;">⁠0.05⁠</code>.
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>weight</code></td>
<td>

<p>Pre-defined weight(s) of stage 1, see
'Details' for more information. Note that using the notation from
Maurer et al, weight corresponds to information fraction, other literature
may refer to sqrt(weight) as being the weight. <code style="white-space: pre;">⁠weight⁠</code> must either
contain one element (in case of <code style="white-space: pre;">⁠max.comb.test = FALSE⁠</code>) or
two elements (in case of <code style="white-space: pre;">⁠max.comb.test = TRUE⁠</code>).<br>
If missing, defaults to <code style="white-space: pre;">⁠0.5⁠</code> for <code style="white-space: pre;">⁠max.comb.test = FALSE⁠</code> and to
<code style="white-space: pre;">⁠c(0.5, 0.25)⁠</code> for <code style="white-space: pre;">⁠max.comb.test = TRUE⁠</code>.
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>max.comb.test</code></td>
<td>

<p>Logical; if <code style="white-space: pre;">⁠TRUE⁠</code> (default) the maximum combination test will be
used, otherwise the standard combination test.
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>targetpower</code></td>
<td>

<p>Desired (overall) target power to declare <abbr><span class="acronym">BE</span></abbr> at the end of the trial.
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>GMR1</code></td>
<td>

<p>Observed ratio of geometric means (T/R) of stage 1 data (use <em>e.g.</em>, 0.95 for 95%).
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>n1</code></td>
<td>

<p>Sample size of stage 1.
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>CV1</code></td>
<td>

<p>Observed coefficient of variation of the intra-subject variability of
stage 1 (use <em>e.g.</em>, 0.3 for 30%).
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>df1</code></td>
<td>

<p>Optional; Error degrees of freedom of
stage 1 that can be specified in
addition to <code>n1</code>.
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>SEM1</code></td>
<td>

<p>Optional; Standard error of the difference of means of
stage 1 that can be specified in
addition to <code>CV1</code>. Must be on additive scale (i.e. usually log-scale).
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>theta1</code></td>
<td>

<p>Lower bioequivalence limit. Defaults to 0.8.
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>theta2</code></td>
<td>

<p>Upper bioequivalence limit. Defaults to 1.25.
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>GMR</code></td>
<td>

<p>Assumed ratio of geometric means (T/R) to be used in power calculation
for stage 1 and sample size re-estimation
for stage 2.
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>usePE</code></td>
<td>

<p>If <code style="white-space: pre;">⁠TRUE⁠</code> the sample size re-estimation is done with the observed
point estimate (<abbr><span class="acronym">PE</span></abbr>) of the treatment difference in
stage 1.<br>
Defaults to <code style="white-space: pre;">⁠FALSE⁠</code>.<br>
Note: The power of stage 1 used for the futility inspection and calculation
of the estimated conditional target power is always calculated with the
planning value <code>GMR</code>.
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>min.n2</code></td>
<td>

<p>Minimum sample size of stage 2. Defaults to 4.<br>
If the sample size re-estimation step gives a sample size for
stage 2 less than <code style="white-space: pre;">⁠min.n2⁠</code>, then
<code style="white-space: pre;">⁠min.n2⁠</code> will be used for stage 2.
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>max.n</code></td>
<td>

<p>Maximum overall sample size stage 1 +
stage 2.<br>
This is <em>not</em> a futility criterion regarding the maximum sample size! If
<code style="white-space: pre;">⁠max.n⁠</code> is set to a finite value and the sample size re-estimation gives a
sample size for stage 2 (<code style="white-space: pre;">⁠n2⁠</code>) such
that <code style="white-space: pre;">⁠n1 + n2 &gt; max.n⁠</code>, then the sample size for
stage 2 will be set to <code style="white-space: pre;">⁠n2 = max.n - n1⁠</code>.<br>
Defaults to <code style="white-space: pre;">⁠Inf⁠</code>, <em>i.e.</em>, no constraint on the re-estimated sample size.
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>fCpower</code></td>
<td>

<p>Threshold for power monitoring step to decide on futility for cases where
<abbr><span class="acronym">BE</span></abbr> has not been achieved after
stage 1: If <abbr><span class="acronym">BE</span></abbr> has not been
achieved after stage 1 and the power for
stage 1 is greater than or equal to
<code style="white-space: pre;">⁠fCpower⁠</code>, then the study will be considered a failure.<br><br>
See ‘Details’ for more information on the choice of
<code style="white-space: pre;">⁠fCpower⁠</code>.
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>fCrit</code></td>
<td>

<p>Futility criterion to use: <code style="white-space: pre;">⁠"No"⁠</code> (no futility criterion regarding
observed point estimate, confidence interval and maximum sample size),
<code style="white-space: pre;">⁠"PE"⁠</code> (observed point estimate of the geometric mean ratio from
stage 1),
<code style="white-space: pre;">⁠"CI"⁠</code> (90% confidence interval of the geometric mean ratio from
stage 1), <code>"Nmax"</code> (overall maximum
sample size); or a combination thereof (concatenate abbreviations).
Defaults to "CI".
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>fClower</code></td>
<td>

<p>Lower futility limit for the <abbr><span class="acronym">PE</span></abbr> or <abbr><span class="acronym">CI</span></abbr> of
stage 1.<br>
If the <abbr><span class="acronym">PE</span></abbr> or <abbr><span class="acronym">CI</span></abbr> is completely outside of <code style="white-space: pre;">⁠fClower⁠</code>
... <code style="white-space: pre;">⁠fCupper⁠</code> the study is to be stopped due to futility (not <abbr><span class="acronym">BE</span></abbr>).<br>
May be missing. If <code style="white-space: pre;">⁠"PE"⁠</code> or <code style="white-space: pre;">⁠"CI"⁠</code> is specified within <code style="white-space: pre;">⁠fCrit⁠</code>,
the default will be set to 0.8 for <code style="white-space: pre;">⁠fCrit = "PE"⁠</code> or 0.95 for <code style="white-space: pre;">⁠fCrit = "CI"⁠</code>.
If neither <code style="white-space: pre;">⁠"PE"⁠</code> nor <code style="white-space: pre;">⁠"CI"⁠</code> is specified within <code style="white-space: pre;">⁠fCrit⁠</code>, there
will be no futility constraint regarding point estimate or confidence interval
from stage 1 (regardless of any
specification of <code style="white-space: pre;">⁠fClower⁠</code> and/or <code style="white-space: pre;">⁠fCupper⁠</code>).
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>fCupper</code></td>
<td>

<p>Upper futility limit for the <abbr><span class="acronym">PE</span></abbr> or <abbr><span class="acronym">CI</span></abbr> of
stage 1.<br>
Analogous to <code style="white-space: pre;">⁠fClower⁠</code>: Will be set to <code style="white-space: pre;">⁠1/fClower⁠</code> if missing.
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>fCNmax</code></td>
<td>

<p>Futility criterion regarding maximum sample size. If the determined sample size
for stage 2 (<code style="white-space: pre;">⁠n2⁠</code>) is such that
<code style="white-space: pre;">⁠n1 + n2 &gt; fCNmax⁠</code>, the study will not continue to
stage 2 and stopped due to futility (not
<abbr><span class="acronym">BE</span></abbr>).<br>
If <code style="white-space: pre;">⁠"Nmax"⁠</code> is specified within <code style="white-space: pre;">⁠fCrit⁠</code> and argument <code style="white-space: pre;">⁠fCNmax⁠</code>
is missing, the value will be set to <code style="white-space: pre;">⁠fCNmax = 4*n1⁠</code>. If <code style="white-space: pre;">⁠"Nmax"⁠</code> is
not specified within <code style="white-space: pre;">⁠fCrit⁠</code>, then there will be no futility constraint
regarding maximum sample size (regardless of any specification of <code style="white-space: pre;">⁠fCNmax⁠</code>).
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>ssr.conditional</code></td>
<td>

<p>Method for sample size re-estimation step: <code style="white-space: pre;">⁠"no"⁠</code> does not use
conditional error rates nor the estimated conditional target power for
the second stage, <code style="white-space: pre;">⁠"error"⁠</code> uses conditional error rates for the
second stage, and <code style="white-space: pre;">⁠"error_power"⁠</code> uses both conditional error rates
and the estimated conditional target power for the second stage.<br>
Defaults to <code style="white-space: pre;">⁠"error_power"⁠</code>.<br><br>
See also ‘Details’.
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>pmethod</code></td>
<td>

<p>Power calculation method, also to be used in the sample size estimation for
stage 2.<br>
Implemented are <code style="white-space: pre;">⁠"nct"⁠</code> (approximate calculations via non-central
<em>t</em>-distribution, <code style="white-space: pre;">⁠"exact"⁠</code> (exact calculations via Owen’s Q),
and <code style="white-space: pre;">⁠"shifted"⁠</code> (approximate calculation via shifted central <em>t</em>-distribution
like in the paper of Potvin <em>et al.</em>)<br>
In contrast to <code>power.tsd.in</code> the default value here is <code style="white-space: pre;">⁠"exact"⁠</code>.
</p>
</td>
</tr>
</table>
<h3>Details</h3>

<p>The observed values of stage 1 (e.g. <code>GMR1</code>, <code>n1</code>, <code>CV1</code>) may
be obtained based on the first stage data via the usual ANOVA approach.<br><br>
The optional arguments <code>df1</code> and <code>SEM1</code> require a somewhat
advanced knowledge (provided in the raw output from for example the software
<abbr><span class="acronym">SAS</span></abbr>, or may be obtained via <code>emmeans::emmeans</code>).
However, it has the advantage that if there were missing data the exact
degrees of freedom and standard error of the difference can be used,
the former possibly being non-integer valued (e.g. if the
Kenward-Roger method was used).<br><br>
The <code>weight</code> argument always refers to the first weight of a pair of
weights. For example, in case of <code>max.comb.test = FALSE</code> the standard
combination test requires two weights (w, 1-w) but only the first one, w,
is required as input argument here because the second weight is
automatically specified once the first is given. Similarly for
<code>max.comb.test = TRUE</code>, w and w* need to be specified, which in turn
define the two pairs of weights (w, 1-w) and (w*, 1-w*).<br><br>
If <code style="white-space: pre;">⁠ssr.conditional = "error_power"⁠</code>, the design scheme generally
calculates the estimated conditional target power of the second stage and
uses this value as desired target power in the sample size re-estimation process:<br>
If <code>fCpower</code> &gt; <code>targetpower</code>, then the conditional estimated
target power may be negative. This does not seem sensible. Therefore, for such
cases the desired target power for the sample size re-calculation will be set
to <code>targetpower</code>, i.e. <code>ssr.conditional</code> will be set to <code>"error"</code>.<br>
Also, if the futility criterion based on the power of stage 1 is met,
then the conditional estimated target power will be negative. Thus, no further
sample size calculation can be made. To acknowledge that this rule is nonbinding,
for the purpose of calculating n2 the argument <code>ssr.conditional</code> is set
to <code>"error"</code>.
</p>


<h3>Value</h3>

<p>Returns an object of class <code style="white-space: pre;">⁠"evaltsd"⁠</code> with all the input arguments and results
as components. As part of the input arguments a component <code>cval</code> is also
presented, containing the critical values for
stage 1 and 2 according to the
input based on <code>alpha</code>, <code>weight</code> and <code>max.comb.test</code>.<br>
The class <code style="white-space: pre;">⁠"evaltsd"⁠</code> has an S3 print method.<br><br>
The results are in the components:
</p>
<table>
<tr style="vertical-align: top;">
<td><code>p11</code></td>
<td>
<p>Observed p-value for first hypothesis.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>p12</code></td>
<td>
<p>Observed p-value for second hypothesis.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>z1</code></td>
<td>
<p>z statistic value for first null hypothesis.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>z2</code></td>
<td>
<p>z statistic value for second null hypothesis.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>RCI</code></td>
<td>
<p>Repeated confidence interval for stage 1. Corresponds to the usual CI with level alpha1.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>MEUE</code></td>
<td>
<p>If the study stops, the median unbiased point estimate as estimate for the final adjusted
geometric mean ratio after stage 1 (note that the value is identical to <code>GMR1</code>.)</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>futility</code></td>
<td>
<p>Three dimensional vector with either 0 or 1. The first
component represents futility due to Power of first stage &gt; <code>fCpower</code>,
the second futility due to <code style="white-space: pre;">⁠CI⁠</code> (or <code style="white-space: pre;">⁠PE⁠</code>) outside of
<code>fClower ... fCupper</code>, the third futility due to
<code>n1 + n2 &gt; fCNmax</code>.<br>
Note that the futility rules can be applied in a non-binding manner.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>CI90</code></td>
<td>
<p>90% Confidence interval for observed ratio of geometric means
from stage 1. If <code style="white-space: pre;">⁠fCrit != "CI"⁠</code> result will be <code>NULL</code>.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>Power Stage 1</code></td>
<td>
<p>Calculated power of stage 1.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>stop_s1</code></td>
<td>
<p>Logical, indicating whether to stop after stage 1
(due to <abbr><span class="acronym">BE</span></abbr> or due to futility).</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>stop_fut</code></td>
<td>
<p>Logical, indicating whether study is recommended to be stopped after
stage 1
due to futility.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>stop_BE</code></td>
<td>
<p>Logical, indicating whether <abbr><span class="acronym">BE</span></abbr> could be concluded after
stage 1 or not (regardless of any
futility criterion).</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>n2</code></td>
<td>
<p>Required (total) sample size for stage 2
(will be zero if <abbr><span class="acronym">BE</span></abbr> has been shown after
stage 1).</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>alpha_ssr</code></td>
<td>
<p>Only applicable if <abbr><span class="acronym">BE</span></abbr> has not been shown after
stage 1. Contains
alpha values for the two hypotheses required for sample size re-calculation.
If <code>ssr.conditional = "no"</code> the result is equal to <code>alpha</code>,
otherwise it contains the conditional error rates for the standard combination
test (in case of <code>max.comb.test = FALSE</code>) or maximum combination test (in
case of <code>max.comb.test = TRUE</code>).</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>GMR_ssr</code></td>
<td>
<p>Only applicable if <abbr><span class="acronym">BE</span></abbr> has not been shown after
stage 1. Contains the
geometric mean ratio used for sample size re-calculation (accounts for
adaptive planning step).</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>targetpower_ssr</code></td>
<td>
<p>Only applicable if <abbr><span class="acronym">BE</span></abbr> has not been shown after
stage 1. Contains the target power used
for the sample size re-calculation (see also 'Details').</p>
</td>
</tr>
</table>
<h3>Author(s)</h3>

<p>B. Lang
</p>


<h3>References</h3>

<p>König F, Wolfsegger M, Jaki T, Schütz H, Wassmer G.<br><em>Adaptive two-stage bioequivalence trials with early stopping and sample size re-estimation.</em><br>
Vienna: 2014; 35<sup>th</sup> Annual Conference of the International Society for Clinical Biostatistics. Poster P1.2.88 <br>
doi: <a href="https://doi.org/10.13140/RG.2.1.5190.0967">10.13140/RG.2.1.5190.0967</a>.
</p>
<p>Patterson SD, Jones B. <em>Bioequivalence and Statistics in Clinical Pharmacology.</em><br>
Boca Raton: CRC Press; 2<sup>nd</sup> edition 2017.
</p>
<p>Maurer W, Jones B, Chen Y. <em>Controlling the type 1 error rate in two-stage
sequential designs when testing for average bioequivalence.</em><br>
Stat Med. 2018; 37(10): 1587–1607. doi: <a href="https://doi.org/10.1002/sim.7614">10.1002/sim.7614</a>.
</p>
<p>Wassmer G, Brannath W. <em>Group Sequential and Confirmatory Adaptive Designs
in Clinical Trials.</em><br>
Springer 2016. doi: <a href="https://doi.org/10.1007/978-3-319-32562-0">10.1007/978-3-319-32562-0</a>.
</p>


<h3>See Also</h3>

<p><code>power.tsd.in, final.tsd.in</code>
</p>


<h3>Examples</h3>

<pre><code class="language-R"># Example from Maurer et al.
interim.tsd.in(GMR = 0.95, max.n = 4000,
               GMR1 = exp(0.0424), CV1 = 0.3682, n1 = 20)
# Example 2 from Potvin et al.
interim.tsd.in(GMR = 0.95, GMR1 = 1.0876, CV1 = 0.18213, n1 = 12,
               fCrit = "No", ssr.conditional = "no")
</code></pre>


</div>